Nikiforow S, Mahadeo K, Chaganti S, et al. Subgroup analysis based on prior treatment from the phase 3 allele study of tabelecleucel for epstein-barr virus-driven post-transplant lymphoproliferative disease [abstract]. Blood. 2025;146(suppl 1):1934.